{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:15:53Z","timestamp":1775819753268,"version":"3.50.1"},"reference-count":60,"publisher":"Tech Science Press","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.32604\/or.2022.027281","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T15:38:00Z","timestamp":1677685080000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells"],"prefix":"10.32604","volume":"31","author":[{"given":"SANDRA","family":"STICKLER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BARBARA","family":"RATH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAXIMILIAN","family":"HOCHMAIR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CLEMENS","family":"LANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUKAS","family":"WEIGL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GERHARD","family":"HAMILTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1101\/gad.263145.115","article-title":"Origins, genetic landscape, and emerging therapies of small cell lung cancer","volume":"29","author":"Semenova","year":"2015","journal-title":"Genes & Development"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.hoc.2016.08.005","article-title":"Advances in small cell lung cancer","volume":"31","author":"Kalemkerian","year":"2017","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10354-015-0381-6","article-title":"Smoking, inflammation and small cell lung cancer: Recent developments","volume":"165","author":"Hamilton","year":"2015","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: Where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14656566.2016.1154539","article-title":"Optimal drugs for second-line treatment of patients with small-cell lung cancer","volume":"17","author":"Rossi","year":"2016","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"ref6","first-page":"39","article-title":"Small cell lung cancer (SCLC): No treatment advances in recent years","volume":"5","author":"Koinis","year":"2016","journal-title":"Translational Lung Cancer Research"},{"key":"ref7","first-page":"51","article-title":"Targeted drugs in small-cell lung cancer","volume":"5","author":"Santarpia","year":"2016","journal-title":"Translational Lung Cancer Research"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.3600","article-title":"Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer","volume":"20","author":"Hodgkinson","year":"2014","journal-title":"Nature Medicine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00408-015-9697-7","article-title":"Circulating tumor cells in lung cancer: Detection methods and clinical applications","volume":"193","author":"Yu","year":"2015","journal-title":"Lung"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1101\/gad.277681.116","article-title":"Distinctive properties of metastasis-initiating cells","volume":"30","author":"Celi\u00e0-Terrassa","year":"2016","journal-title":"Genes & Development"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00408-015-9725-7","volume":"193","author":"Hamilton","year":"2015","journal-title":"Lung"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1038\/s41598-017-05562-z","article-title":"Small cell lung cancer: Model of circulating tumor cell tumorospheres in chemoresistance","volume":"7","author":"Klameth","year":"2017","journal-title":"Scientific Reports"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10911-016-9359-2","article-title":"Generation of multicellular breast cancer tumor spheroids: Comparison of different protocols","volume":"21","author":"Froehlich","year":"2016","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","article-title":"Three-dimensional culture systems in cancer research: Focus on tumor spheroid model","volume":"163","author":"Nath","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","article-title":"Multicellular tumor spheroids: An underestimated tool is catching up again","volume":"148","author":"Hirschhaeuser","year":"2010","journal-title":"Journal of Biotechnology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.2451290","article-title":"Cell and environment interactions in tumor microregions: The multicell spheroid model","volume":"240","author":"Sutherland","year":"1988","journal-title":"Science"},{"key":"ref18","first-page":"878","article-title":"Limited penetration of anticancer drugs through tumor tissue: A potential cause of resistance of solid tumors to chemotherapy","volume":"8","author":"Tannock","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1040-8428(00)00086-X","article-title":"Multicellular resistance: A paradigm for clinical resistance?","volume":"36","author":"Desoize","year":"2000","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00001622-199711000-00010","article-title":"Cell adhesion and drug resistance in cancer. A major role for cell-cell adhesion in the regulation of intrinsic or acquired resistance","volume":"9","author":"Croix","year":"1997","journal-title":"Current Opinion in Oncology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.bjc.6602710","article-title":"A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs","volume":"93","author":"Mellor","year":"2005","journal-title":"British Journal of Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.18632\/oncotarget.13857","article-title":"Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment","volume":"8","author":"D\u00e4ster","year":"2017","journal-title":"Oncotarget"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-13-73","article-title":"Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D","volume":"13","author":"Laurent","year":"2013","journal-title":"BMC Cancer"},{"key":"ref24","first-page":"8924","article-title":"Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer","volume":"61","author":"Olive","year":"2001","journal-title":"Cancer Research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e34279","DOI":"10.1371\/journal.pone.0034279","article-title":"Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair","volume":"7","author":"Zschenker","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","article-title":"Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy","volume":"164","author":"Mehta","year":"2012","journal-title":"Journal of Controlled Release"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1242\/bio.2012653","article-title":"Spontaneous spheroid budding from monolayers: A potential contribution to ovarian cancer dissemination","volume":"1","author":"Pease","year":"2012","journal-title":"Biology Open"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/17460441.2013.768984","article-title":"How can attrition rates be reduced in cancer drug discovery?","volume":"8","author":"Moreno","year":"2013","journal-title":"Expert Opinion on Drug Discovery"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ctrv.2016.10.009","article-title":"Factors associated with failure of oncology drugs in late-stage clinical development: A systematic review","volume":"52","author":"Jardim","year":"2017","journal-title":"Cancer Treatment Reviews"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-017-0601-3","article-title":"Catching moving targets: Cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention","volume":"16","author":"Gasch","year":"2017","journal-title":"Molecular Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: A high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"ref32","first-page":"71","article-title":"Second-line therapy for small cell lung cancer: Exploring the potential role of circulating tumor cells","volume":"5","author":"Hamilton","year":"2016","journal-title":"Translational Lung Cancer Research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/1087057106292763","article-title":"Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis","volume":"11","author":"Ivascu","year":"2006","journal-title":"Journal of Biomolecular Screening"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/adt.2018.895","article-title":"Quantitative size-based analysis of tumor spheroids and responses to therapeutics","volume":"17","author":"Thakuri","year":"2019","journal-title":"ASSAY and Drug Development Technologies"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2017.12.005","article-title":"Application of 3D cultured multicellular spheroid tumor models in tumor targeted drug delivery system research","volume":"270","author":"Huang","year":"2018","journal-title":"Journal of Controlled Release"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.3.1.1","volume":"3","author":"Smalley","year":"2008","journal-title":"Expert Opinion on Drug Discovery"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1098\/rsif.2016.0877","article-title":"Advances in multicellular spheroids formation","volume":"14","author":"Cui","year":"2017","journal-title":"Journal of the Royal Society Interface"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"41160","DOI":"10.1038\/srep41160","article-title":"Spheroid arrays for high throughput single cell analysis of spatial patterns and biomarker expression in 3D","volume":"7","author":"Ivanov","year":"2017","journal-title":"Scientific Reports"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"16948","DOI":"10.18632\/oncotarget.7659","volume":"7","author":"Raghavan","year":"2016","journal-title":"Oncotarget"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.18632\/oncotarget.13857","article-title":"Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment","volume":"8","author":"Silvio","year":"2017","journal-title":"Oncotarget"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.21037\/tlcr-22-58","article-title":"Comparative characteristics of small cell lung cancer and Ewing\u2019s sarcoma: A narrative review","volume":"11","author":"Hamilton","year":"2022","journal-title":"Translational Lung Cancer Research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10517-020-05018-x","article-title":"Expression of epithelial cell adhesion molecule (EpCAM) in tumor spheroids of human colorectal adenocarcinoma cells","volume":"170","author":"Gisina","year":"2020","journal-title":"Bulletin of Experimental Biology and Medicine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.2174\/1381612820666140619123255","article-title":"SPARC in tumor pathophysiology and as a potential therapeutic target","volume":"20","author":"Feng","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13036-018-0120-9","volume":"12","author":"Pradhan","year":"2018","journal-title":"Journal of Biological Engineering"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1600-0463.2008.01213.x","article-title":"Tumor-vascular interactions and tumor dormancy","volume":"116","author":"Naumov","year":"2008","journal-title":"Apmis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2010.03.004","article-title":"Molecular mechanisms underlying tumor dormancy","volume":"294","author":"Almog","year":"2010","journal-title":"Cancer Letters"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nature Cell Biology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent EpCAM protein expression in human carcinomas","volume":"35","author":"Went","year":"2004","journal-title":"Human Pathology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/pin.12404","article-title":"Higher expression of EpCAM is associated with poor clinical and pathological responses in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"66","author":"Ohashi","year":"2016","journal-title":"Pathology International"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamem.2013.04.018","article-title":"EpCAM: Structure and function in health and disease","volume":"1828","author":"Schnell","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"24677","DOI":"10.18632\/oncotarget.8250","article-title":"Epithelial-to-mesenchymal transition leads to loss of EpCAM and di_erent physical properties in circulating tumor cells from metastatic breast cancer","volume":"7","author":"Hyun","year":"2016","journal-title":"Oncotarget"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/19336918.2016.1155019","article-title":"Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype","volume":"10","author":"Hamilton","year":"2016","journal-title":"Cell Adhesion Migration"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"12569","DOI":"10.1002\/jcp.28132","article-title":"Shedding light on the EpCAM: An overview","volume":"234","author":"Yahyazadeh Mashhadi","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/biom10020255","article-title":"Revisiting the roles of pro-metastatic EpCAM in cancer","volume":"10","author":"Mohtar","year":"2020","journal-title":"Biomolecules"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"12253","DOI":"10.1074\/jbc.M113.457499","article-title":"Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions","volume":"288","author":"Wu","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"23373","DOI":"10.1038\/srep23373","article-title":"Transcriptome profile of the early stages of breast cancer tumoral spheroids","volume":"6","author":"Pacheco-Mar\u00edn","year":"2016","journal-title":"Scientific Reports"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2147\/OTT.S298427","article-title":"3D culture of circulating tumor cells for evaluating early recurrence and metastasis in patients with hepatocellular carcinoma","volume":"14","author":"Hu","year":"2021","journal-title":"Oncology Targets Therapy"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2022.02.008","article-title":"EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients","volume":"167","author":"Mederer","year":"2022","journal-title":"Lung Cancer"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"12270","DOI":"10.1038\/srep12270","article-title":"EpCAM+ and EpCAM\u2212 circulating tumor cells","volume":"5","author":"de Wit","year":"2015","journal-title":"Scientific Reports"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2174\/1568009618666180102102311","article-title":"Antibody based EpCAM targeted therapy of cancer, review and update","volume":"18","author":"Eyvazi","year":"2018","journal-title":"Current Cancer Drug Targets"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2023\/TSP_OR-31-1\/OncolRes-31-01-27281\/OncolRes-31-27281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:59:35Z","timestamp":1733522375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v31n1\/51751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2022.027281","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"2022-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-01","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}